Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Corning Incorporated Fourth Quarter 2025 Earnings Call - Springboard upgraded to $11B by 2028, Meta deal anchors U.S. optical expansion
Corning closed 2025 with a clean one-two punch, beating on growth and profitability and then upgrading the playbook. Q4 sales rose 14% to $4.41 billion, EPS jumped 26% to $0.72, operating margin hit 2...
- Q4 2025 sales grew 14% year-over-year to $4.41 billion; EPS rose 26% to $0.72; operating margin expanded to 20.2%, hitting the Springboard 20% target a year early.
- Springboard upgraded: internal plan now targets $11 billion of incremental annualized sales by the end of 2028, up from the original $8 billion.
- Near-term upgrade: internal Springboard now adds $6.5 billion by end-2026 (previously $6.0B); high-confidence plan now adds $5.75 billion by end-2026 (previously $4.0B).
- +13 more takeaways
Littelfuse Fourth Quarter 2025 Earnings Call - Basler Deal and Data Center Momentum Set Up High-Power Growth
Littelfuse closed 2025 with tangible operational progress and a strategic pivot toward high-power markets, led by the December acquisition of Basler Electric. Q4 revenue came in at $594 million, up 12...
- Littelfuse reported Q4 revenue of $594 million, up 12% year over year and up 7% on an organic basis.
- Adjusted EBITDA margin in Q4 was 20.5%, up 480 basis points year over year, and adjusted diluted EPS was $2.69.
- The company closed the Basler Electric acquisition in December, expecting Basler to add $130 million to $135 million of revenue and $0.10 to $0.15 of adjusted EPS in 2026.
- +13 more takeaways
Elevance Health Fourth Quarter 2025 Earnings Call - 2026 Year of Execution, EPS Guidance at Least $25.50 as Medicaid Hits a Trough
Elevance walked investors through a year of repositioning for 2026, setting adjusted diluted EPS guidance of at least $25.50 while calling 2026 a trough year for Medicaid. Management flagged meaningfu...
- Adjusted diluted EPS: $3.33 in Q4 2025, $30.29 for full year 2025; results included about $3.75 per share of favorable non-recurring items.
- Management set 2026 adjusted diluted EPS guidance of at least $25.50, calling 2026 a year of execution and repositioning.
- Membership ended 2025 at 45.2 million, down roughly 500,000 year over year, driven principally by Medicaid reverification impacts.
- +12 more takeaways
Orrstown Financial Services, Inc. Q4 2025 Earnings Call - Record 2025 Net Income, NIM Near Peer Top
Orrstown closed 2025 with the strongest annual profit in its 106-year history, reporting $80.9 million of net income and a full-year net interest margin near the top of regional peers. Q4 momentum car...
- Record annual net income of $80.9 million for 2025, the highest in the company’s 106-year history; Q4 net income was $21.5 million, or $1.11 per diluted share.
- Net interest margin held near peer top, 4.04% for the year and 4.00% in Q4, despite quarter-over-quarter compression driven by lower variable loan yields and purchase accounting dynamics.
- Management guides 2026 NIM to a range of 3.90% to 4.00%, expecting funding costs to decline starting Q1 2026; if Fed cuts do not materialize, NIM could be higher.
- +12 more takeaways
Danaher Corporation Fourth Quarter 2025 Earnings Call - Bioprocessing Strength Anchors 2026 Guide (3%-6% Core Revenue, $8.35-$8.50 EPS)
Danaher closed 2025 with clear momentum in bioprocessing and enough diagnostic tailwinds to beat street expectations, but management is deliberately conservative on equipment recovery and life science...
- Full year 2025 sales $24.6 billion; core revenue increased 2% year over year.
- Adjusted operating profit margin for 2025 was 28.2%; adjusted diluted EPS $7.80, up 4.5% versus prior year.
- Free cash flow for 2025 was $5.3 billion, with free cash flow to net income conversion of approximately 145%, the 34th consecutive year above 100%.
- +12 more takeaways
Starbucks Q1 Fiscal 2026 Earnings Call - Turnaround Gains Traction as Transactions Drive Top-Line Growth
Starbucks says the long-awaited turnaround is showing up where it matters, in transactions. Q1 top line beat the headline skeptics: revenue rose 5% to $9.9 billion, global comps accelerated to +4%, an...
- Q1 revenue $9.9 billion, up 5% year over year, with global comparable store sales +4%.
- U.S. company-operated comps +4%, driven by transactions up 3%, the first positive transaction growth in eight quarters.
- Starbucks Rewards 90-day active members reached a record 35.5 million, and Rewards transactions grew year over year for the first time in eight quarters.
- +12 more takeaways
Monro Inc Q3 FY2026 Earnings Call - Operational overhaul starts to pay off with positive comps, margin lift, and real estate monetization
Monro says its fiscal Q3 was the quarter the turnaround began to feel real. After closing 145 underperforming locations and beefing up marketing, merchandising, and field tools, the chain delivered po...
- Sales declined 4.0% to $293.4 million in Q3, primarily due to the closure of 145 underperforming stores earlier in the fiscal year.
- Comparable store sales for continuing locations increased 1.2% in Q3, marking the fourth consecutive quarter of positive comps and the first positive two-year stack in over two years when adjusting for holiday timing.
- Tire category strength: tire sales were up 5% year-over-year, while tire units were down 1%, suggesting mix and pricing gains.
- +16 more takeaways
Teva Pharmaceutical Industries Q4 2025 Earnings Call - Innovation-led growth is real, but milestone cash and inventory quirks muddy the picture
Teva closed 2025 on a clear theme, one they have been selling since the Pivot to Growth launch: the company is no longer a pure generics shop, it is a biopharma company driven by a fast-growing innova...
- Management doubled down on the Pivot to Growth narrative: Teva says its business is shifting from generics to a diversified biopharma with four strategic pillars and focused capital allocation.
- Q4 GAAP revenue was reported at approximately $4.2 billion, up 2% year-over-year in USD (down 1% in local currency). Q4 GAAP net income was $480 million, GAAP EPS $0.41.
- Company-reported adjusted EBITDA rose 12% to $5.3 billion (management figure), and non-GAAP gross margin for the full year was 54.7%, above guidance range; non-GAAP operating margin slipped to 26.7% due to higher OpEx investments.
- +13 more takeaways
Extreme Networks Q2 Fiscal Year 2026 Earnings Call - Platform One AI sales lift revenue and share gains, installations dent near-term margins
Extreme reported a clean beat: revenue of $318 million, up 14% year over year, driven by accelerating SaaS and product momentum. Management leaned hard into Platform One, calling it agentic AI and say...
- Revenue beat and growth: Q2 revenue $318 million, up 14% year over year and above the high end of guidance, marking the seventh consecutive quarter of revenue growth.
- SaaS ARR acceleration: SaaS ARR reached $227 million, up 25% year over year, driven largely by Platform One momentum.
- Record subscription bookings: Management said subscription bookings were the strongest on record, with Platform One bookings roughly twice internal targets for the quarter.
- +16 more takeaways
New Oriental FY2026 Q2 Earnings Call - K-12 Rebound and Cost Discipline Lift Revenue 14.7% and Non‑GAAP Op Margin +470 bps
New Oriental posted a crisp quarter: total net revenue rose 14.7% year‑over‑year to $1.19 billion, while non‑GAAP operating income more than tripled to $89.1 million and non‑GAAP net income jumped 68....
- Total net revenue $1.19 billion in Q2, up 14.7% year‑over‑year.
- Non‑GAAP operating income $89.1 million, up 206.9% year‑over‑year; non‑GAAP net income $72.9 million, up 68.6%.
- Non‑GAAP operating margin expanded materially, management cited roughly +470 basis points year‑over‑year (over 4 percentage points).
- +13 more takeaways